ScoreWhy is Runben Biotechnology Co., Ltd. ?
1
Positive results in Jun 25
- INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
- NET SALES(Q) Highest at CNY 649.78 MM
- OPERATING PROFIT(Q) Highest at CNY 166.23 MM
2
With ROE of 13.97%, it has a attractive valuation with a 0.82 Price to Book Value
- Over the past year, while the stock has generated a return of 7.68%, its profits have risen by 31%
- At the current price, the company has a high dividend yield of 1.5
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Runben Biotechnology Co., Ltd. should be less than 10%
- Overall Portfolio exposure to FMCG should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in FMCG)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Runben Biotechnology Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Runben Biotechnology Co., Ltd.
10.79%
0.58
43.24%
China Shanghai Composite
15.19%
1.01
14.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
31.30%
EBIT Growth (5y)
30.32%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.65
Sales to Capital Employed (avg)
85.30
Tax Ratio
14.76%
Dividend Payout Ratio
55.26%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
28.62%
ROE (avg)
13.24%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
0.82
EV to EBIT
1.11
EV to EBITDA
1.04
EV to Capital Employed
0.48
EV to Sales
0.25
PEG Ratio
NA
Dividend Yield
1.47%
ROCE (Latest)
43.16%
ROE (Latest)
13.97%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
NET SALES(Q)
Highest at CNY 649.78 MM
OPERATING PROFIT(Q)
Highest at CNY 166.23 MM
PRE-TAX PROFIT(Q)
Highest at CNY 173.72 MM
NET PROFIT(Q)
Highest at CNY 146.68 MM
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Runben Biotechnology Co., Ltd.
Net Sales
Highest at CNY 649.78 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 166.23 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Pre-Tax Profit
Highest at CNY 173.72 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 146.68 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
